Connect with us

Technology

Shoulder Innovations to Participate in the Canaccord Genuity 46th Annual Growth Conference

Published

on

GRAND RAPIDS, Mich., July 29, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will present at the Canaccord Genuity 46th Annual Growth Conference. The presentation will take place at 1:30 p.m. ET / 10:30 a.m. PT on Wednesday, August 12, 2026.

A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations

Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact 
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference-302838112.html

SOURCE Shoulder Innovations

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES DATES OF ITS 2026 SECOND QUARTER EARNINGS RELEASE AND CONFERENCE CALL

Published

on

By

GLEN ALLEN, Va., July 29, 2026 /PRNewswire/ — Hamilton Beach Brands Holding Company (NYSE: HBB) announced today that it will release its 2026 second quarter financial results and file its 10-Q for the quarter ended June 30, 2026, after the market close on Wednesday, August 5, 2026.

The Company will host a conference call on Wednesday, August 5, 2026, to discuss its results. 

Conference Call: 

Wednesday, August 5, 2026

Time:                  

4:30 p.m. (Eastern Time)

Telephone:        

833-461-5787 (toll free) International 585-542-9983

Conference ID: 561620015

(Call in at least five minutes before start time)

The conference call will be webcast live over the internet. To listen to the webcast, please select Events & Presentations from the Investors tab of the Hamilton Beach Brands Holding Company website at www.hamiltonbeachbrands.com. Please allow 15 minutes to register, download and install any necessary software. An archive of the webcast will be available on the company website.

About Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Company is a leading designer, marketer, and distributor of a wide range of brandname small electric household and specialty housewares appliances, and commercial products for restaurants, fast food chains, bars, and hotels, and is a provider of connected devices and software for healthcare management. The Company’s owned consumer brands include Hamilton Beach®, Proctor Silex® and Weston®, as well as premium brands Hamilton Beach Professional® and Lotus®. The Company’s owned commercial brands include Hamilton Beach Commercial® and Proctor Silex Commercial®. The Company licenses the brands for CHI® premium garment care products and CloroxTM home appliances. The Company has multiyear agreements to design, sell, market, and distribute Numilk® plant-based milk makers and Sunkist® commercial juicers and sectionizers. Hamilton Beach Health, which owns HealthBeacon, is expanding the Company’s presence in the home health and medical markets through connected medical devices. For more information about Hamilton Beach Brands Holding Company, visit www.hamiltonbeachbrands.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hamilton-beach-brands-holding-company-announces-dates-of-its-2026-second-quarter-earnings-release-and-conference-call-302837514.html

SOURCE Hamilton Beach Brands Holding Company

Continue Reading

Technology

Cohen & Steers Closed-end Opportunity Fund, Inc. Issues Important Notice Regarding Change in Investment Policy and Investment Strategy

Published

on

By

NEW YORK, July 29, 2026 /PRNewswire/ — Cohen & Steers Closed-end Opportunity Fund, Inc. (NYSE:FOF) (the “Fund”), announced today that the Fund’s Board of Directors has approved certain changes to the Fund’s 80% investment policy and related investment strategy disclosure. The changes will be effective October 1, 2026 (the “Effective Time”).

At the Effective Time, the existing 80% policy will be replaced with the following new policy: Under normal circumstances, at least 80% of the Fund’s net assets will be invested in common stock or other securities issued by Portfolio Funds which are listed on a U.S. or non-U.S. securities exchange.

Additionally, at the Effective Time, the Fund’s disclosure will be revised to define “Portfolio Fund” as any closed-end pooled investment vehicle and state that the Fund will consider an investment vehicle to be “closed-end” if it does not offer a daily redemption or repurchase right.  As a result of these changes, the Fund will have more flexibility under its 80% policy to invest in a broad range of U.S. and non-U.S. investment vehicles, including vehicles that are not registered under the Investment Company Act of 1940. In connection with the above changes, as of the Effective Time, the Fund is adopting the following investment strategy disclosure:

The Fund seeks to achieve its objective by investing in the common stock of closed-end pooled investment vehicles (collectively, Portfolio Funds) selected by the Fund’s investment manager that invest significantly in equity securities, income-producing securities or other assets, including precious metals and other commodities, real assets and derivatives. Portfolio Funds may invest in both publicly traded and private investments. Types or categories of Portfolio Funds may include, but are not limited to, Portfolio Funds that invest in the following asset classes:

Bank Loans;Convertible Securities;Commodities;Municipal Securities;Income Securities;High Yield Municipal Securities;MLPs;Option Income/Covered Calls;Preferred Securities;Private Credit;Private Equity;Private Real Estate;REITs and other Real Estate Securities;Short Duration Securities;Single Commodity Precious Metals;Taxable Municipal Securities;U.S. General Equity;U.S. High Yield Securities;U.S. Hybrid;U.S. Multi-Sector Securities;U.S. Sector Bond;U.S. Sector Equity;Utilities.

Shares of Portfolio Funds in which the Fund invests will be traded on a U.S. or non-U.S. securities exchange.

Securities and other investments in which Portfolio Funds are expected to focus their investments, along with equity, convertible, preferred and high yield securities and the real estate, energy and utilities sectors, are described with their accompanying risks, under “Principal Risks of the Fund—Portfolio Fund Investment Risk.”

Under normal circumstances, at least 80% of the Fund’s net assets will be invested in common stock or other securities issued by Portfolio Funds which are listed on a U.S. or non-U.S. securities exchange. The Fund will consider an investment vehicle to be “closed-end” if it does not offer a daily redemption or repurchase right. The Fund is unconstrained from an investment perspective with respect to location of Portfolio Funds (e.g., U.S. or non-U.S.), types of interests purchased by Portfolio Funds (i.e., equity or fixed income), strategy/assets held by Portfolio Funds (e.g., precious metals, municipal securities) and whether a Portfolio Fund purchases publicly or privately offered securities. Although most Portfolio Funds are expected to be registered under the 1940 Act, some will not and therefore will not provide investors, such as the Fund, with the protections of the 1940 Act. The Fund’s allocations across different types of Portfolio Funds will vary over time, perhaps significantly. The Fund also has the ability to invest directly in equity, income-producing securities, precious metals and other instruments relating to closed-end funds.

In selecting Portfolio Funds, the investment manager seeks to identify closed-end funds that meet one or more of the following characteristics:

strong fundamentals, including ability to meet current and projected future dividend payments out of current income or a combination of current income and realized and unrealized gains, and leverage/risk management, as the investment manager believes that a conservative approach to leverage has the potential to help mitigate the effects of changes in interest rates;relatively high current income;share prices at a discount to net asset value;undervalued funds where recent total return on market price trails recent total return on net asset value;well-regarded asset managers with strong track records managing the asset class(es) in which a Portfolio Fund invests;diversification of sectors and asset classes among the Portfolio Funds;market capitalization generally greater than $200 million; andaverage daily trading volumes generally greater than $750,000 per day.

There is no requirement that any Portfolio Fund in the Fund’s portfolio satisfy all the criteria set forth above, and the investment manager will use its discretion in selecting a portfolio of Portfolio Funds that the investment manager believes will help the Fund achieve its investment objective.

In addition to the criteria set forth above, the investment manager also may invest opportunistically in one or more Portfolio Funds when the investment manager believes a Portfolio Fund’s shares are not appropriately priced relative to other comparable funds or the Portfolio Fund’s share price does not properly reflect the impact of a corporate event or conditions in the overall securities markets that the investment manager believes will have a positive influence on the Portfolio Fund’s share price.

The Fund will be limited by provisions of the 1940 Act that limit the amount the Fund can invest in any one Portfolio Fund to 3% of the Portfolio Fund’s total outstanding stock. As a result, the Fund may hold a smaller position in a Portfolio Fund than if it were not subject to this restriction. To comply with provisions of the 1940 Act, on any matter upon which Portfolio Fund stockholders are solicited to vote the investment manager will vote Portfolio Fund shares in the same general proportion as shares held by other stockholders of the Portfolio Fund.

The Fund may invest in securities of other closed-end or open-end funds, including exchange traded funds (ETFs) and funds managed by the investment manager, in accordance with Section 12(d)(1) of the 1940 Act and the rules thereunder, or any exemption granted under the 1940 Act.

The Fund may, but is not required to, use, without limit, various derivatives transactions to seek to generate return, facilitate portfolio management and mitigate risks. Although the Fund’s investment manager may seek to use these kinds of transactions to further the Fund’s investment objectives, no assurance can be given that they will achieve this result. The Fund may enter into (buy or sell) exchange-listed and over-the-counter put and call options on securities (including securities of investment companies and baskets of securities), indices, and other financial instruments; purchase and sell financial futures contracts and options thereon; enter into various interest rate transactions, such as swaps, caps, floors or collars or credit transactions; equity index, total return and credit default swaps; forward contracts; and structured investments. In addition, the Fund may enter into various currency transactions, such as forward currency contracts, currency futures contracts, currency swaps or options on currency or currency futures. The Fund also may purchase and sell derivative instruments that combine features of these instruments. The Fund may invest in other types of derivatives, structured and similar instruments which are not currently available but which may be developed in the future.

The Fund may buy and sell shares of Portfolio Funds to take advantage of potential short-term trading opportunities, but short-term trading will not be used as the primary means of achieving the Fund’s investment objective.

Temporary Defensive Positions. When the investment manager believes that market or general economic conditions justify a temporary defensive position, the Fund may deviate from its investment objectives and invest all or any portion of its assets in investment grade debt securities. In such a case, the Fund may not pursue or achieve its investment objective.

The information contained in this notice is provided for informational purposes only and does not constitute a solicitation of an offer to buy or sell Fund shares.

For more information, please visit our website at www.cohenandsteers.com or call (866) 227-0757.

Website: https://www.cohenandsteers.com/
Symbols: (NYSE: CNS, FOF)

View original content:https://www.prnewswire.com/news-releases/cohen–steers-closed-end-opportunity-fund-inc-issues-important-notice-regarding-change-in-investment-policy-and-investment-strategy-302838246.html

SOURCE Cohen & Steers, Inc.

Continue Reading

Technology

Lam Research Corporation Reports Financial Results for the Quarter Ended June 28, 2026

Published

on

By

FREMONT, Calif., July 29, 2026 /PRNewswire/ — Lam Research Corporation (the “Company,” “Lam,” “Lam Research”) today announced financial results for the quarter ended June 28, 2026 (the “June 2026 quarter”).

Highlights for the June 2026 quarter were as follows:

Revenue of $6.72 billion.U.S. GAAP gross margin as a percent of revenue of 51.7%, U.S. GAAP operating margin as a percent of revenue of 37.4%, and U.S. GAAP diluted EPS of $1.81.Non-GAAP gross margin as a percent of revenue of 52.0%, non-GAAP operating margin as a percent of revenue of 38.4%, and non-GAAP diluted EPS of $1.82.

 

Key Financial Data for the Quarters Ended 
June 28, 2026 and March 29, 2026 
(in thousands, except per-share data, percentages, and basis points)  

U.S. GAAP

June 2026

March 2026

Change Q/Q

Revenue

$          6,722,238

$          5,841,488

+15.1 %

Gross margin

51.7 %

49.8 %

+ 190 bps

Operating margin

37.4 %

35.0 %

+ 240 bps

Diluted EPS

$                   1.81

$                   1.45

+24.8 %

Non-GAAP

June 2026

March 2026

Change Q/Q

Revenue

$          6,722,238

$          5,841,488

+15.1 %

Gross margin

52.0 %

49.9 %

+ 210 bps

Operating margin

38.4 %

35.0 %

+ 340 bps

Diluted EPS

$                   1.82

$                   1.47

+23.8 %

U.S. GAAP Financial Results

For the June 2026 quarter, revenue was $6.72 billion, gross margin was $3.48 billion, or 51.7% of revenue, operating expenses were $965.3 million, operating margin was 37.4% of revenue, and net income was $2.28 billion, or $1.81 per diluted share on a U.S. GAAP basis. This compares to revenue of $5.84 billion, gross margin of $2.91 billion, or 49.8% of revenue, operating expenses of $863.5 million, operating margin of 35.0% of revenue, and net income of $1.83 billion, or $1.45 per diluted share, for the quarter ended March 29, 2026 (the “March 2026 quarter”).

Non-GAAP Financial Results

For the June 2026 quarter, non-GAAP gross margin was $3.50 billion, or 52.0% of revenue, non-GAAP operating expenses were $916.4 million, non-GAAP operating margin was 38.4% of revenue, and non-GAAP net income was $2.28 billion, or $1.82 per diluted share. This compares to non-GAAP gross margin of $2.91 billion, or 49.9% of revenue, non-GAAP operating expenses of $866.2 million, non-GAAP operating margin of 35.0% of revenue, and non-GAAP net income of $1.85 billion, or $1.47 per diluted share, for the March 2026 quarter.

“Lam delivered record revenue, operating margin and earnings per share in the June quarter as AI-driven demand continues to reshape the semiconductor industry,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “Our strategic investments and technology leadership are helping customers accelerate through rising manufacturing complexity, positioning Lam for a third consecutive year of outperformance in 2026.”

Balance Sheet and Cash Flow Results

Cash, cash equivalents, and restricted cash balances increased to $5.60 billion at the end of the June 2026 quarter compared to $4.77 billion at the end of the March 2026 quarter. The increase was primarily driven by cash generated from operating activities, partially offset by cash deployed for capital return activities during the quarter.

Deferred revenue at the end of the June 2026 quarter increased to $2.43 billion compared to $2.22 billion as of the end of the March 2026 quarter. Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $490.2 million as of June 28, 2026 and $434.3 million as of March 29, 2026.

Revenue

The geographic distribution of revenue during the June 2026 quarter is shown in the following table:

Region

Revenue

Taiwan

27 %

China

26 %

Korea

20 %

Japan

9 %

United States

9 %

Southeast Asia

5 %

Europe

4 %

The following table presents revenue disaggregated between systems and customer support-related revenue:

Three Months Ended

June 28,
2026

March 29,
2026

June 29,
2025

(In thousands)

Systems revenue

$    4,249,848

$    3,730,582

$    3,437,625

Customer support-related revenue and other

2,472,390

2,110,906

1,733,768

$    6,722,238

$    5,841,488

$    5,171,393

Systems revenue includes sales of new leading-edge equipment in deposition, etch and other wafer fabrication markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.

Outlook

For the quarter ended September 27, 2026, Lam is providing the following guidance:

U.S. GAAP

Reconciling
Items

Non-GAAP

Revenue

$8.10 Billion

+/-

$400 Million

$8.10 Billion

+/-

$400 Million

Gross margin

52.0 %

+/-

1 %

$  2.7

Million

52.0 %

+/-

1 %

Operating margin

39.5 %

+/-

1 %

$  3.0

Million

39.5 %

+/-

1 %

Net income per diluted share

$2.15

+/-

$0.15

$  3.3

Million

$2.15

+/-

$0.15

Diluted share count

1.255 Billion

1.255 Billion

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other items that may be completed or realized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

Gross margin – amortization related to intangible assets acquired through business combinations, $2.7 million.Operating margin – amortization related to intangible assets acquired through business combinations, $3.0 million.Net income per diluted share – amortization related to intangible assets acquired though business combinations, $3.0 million; amortization of debt discounts, $0.5 million; and associated tax benefit for non-GAAP items ($0.2 million); totaling $3.3 million.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the June 2026 and March 2026 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, workforce optimization charges, and the net income tax effect of non-GAAP items.

Management uses non-GAAP gross margin, operating expense, operating income, operating margin, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating margin, net income per diluted share, and diluted share count; the effect of AI-driven demand on the semiconductor industry; the rising complexity of semiconductor manufacturing and the extent to which our investments and technology leadership help customers; and our positioning for outperformance. Some factors that may affect these forward-looking statements include: business, economic, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, tariffs, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; supply chain cost increases, tariffs, export controls and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions, export controls or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam’s equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX)

Consolidated Financial Tables Follow.

 

 

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)

Three Months Ended

Twelve Months Ended

June 28,
2026

March 29,
2026

June 29,
2025

June 28,
2026

June 29,
2025

(unaudited)

(unaudited)

(unaudited)

(unaudited)

(1)

Revenue

$ 6,722,238

$ 5,841,488

$ 5,171,393

$ 23,232,690

$ 18,435,591

Cost of goods sold

3,243,498

2,930,961

2,581,684

11,507,382

9,456,532

Gross margin

3,478,740

2,910,527

2,589,709

11,725,308

8,979,059

Gross margin as a percent of revenue

51.7 %

49.8 %

50.1 %

50.5 %

48.7 %

Research and development

642,922

583,200

580,178

2,375,873

2,096,387

Selling, general and administrative

322,330

280,311

268,403

1,149,640

981,704

Total operating expenses

965,252

863,511

848,581

3,525,513

3,078,091

Operating income

2,513,488

2,047,016

1,741,128

8,199,795

5,900,968

Operating margin

37.4 %

35.0 %

33.7 %

35.3 %

32.0 %

Other income (expense), net

41,654

(35,460)

37,853

62,678

57,161

Income before income taxes

2,555,142

2,011,556

1,778,981

8,262,473

5,958,129

Income tax expense

(277,860)

(186,096)

(58,893)

(997,077)

(599,912)

Net income

$ 2,277,282

$ 1,825,460

$ 1,720,088

$ 7,265,396

$  5,358,217

Net income per share:

Basic

$          1.82

$          1.46

$          1.35

$           5.79

$           4.17

Diluted

$          1.81

$          1.45

$          1.35

$           5.76

$           4.15

Number of shares used in per share calculations:

Basic

1,251,286

1,249,728

1,274,279

1,255,079

1,286,101

Diluted

1,256,032

1,257,325

1,276,933

1,261,102

1,290,142

Cash dividend declared per common share

$          0.26

$          0.26

$          0.23

$           1.04

$           0.92

(1)

Derived from audited financial statements

 

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)

June 28,
2026

March 29,
2026

June 29,
2025

(unaudited)

(unaudited)

(1)

ASSETS

Cash and cash equivalents

$         5,579,171

$         4,750,936

$         6,390,659

Accounts receivable, net

5,339,682

4,132,890

3,378,071

Inventories

4,276,111

3,999,992

4,307,991

Prepaid expenses and other current assets

415,741

413,099

440,274

Total current assets

15,610,705

13,296,917

14,516,995

Property and equipment, net

2,956,472

2,853,614

2,428,744

Goodwill and intangible assets

1,895,859

1,882,017

1,808,685

Other assets

3,066,707

2,759,362

2,590,836

Total assets

$        23,529,743

$        20,791,910

$        21,345,260

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current portion of long-term debt and finance lease obligations

$                 4,073

$                 4,095

$              754,311

Other current liabilities

5,933,176

5,238,303

5,814,114

Total current liabilities

5,937,249

5,242,398

6,568,425

Long-term debt and finance lease obligations

3,730,490

3,730,384

3,730,194

Income taxes payable

681,197

621,572

603,412

Other long-term liabilities

709,886

612,777

581,610

Total liabilities

11,058,822

10,207,131

11,483,641

Stockholders’ equity (2)

12,470,921

10,584,779

9,861,619

Total liabilities and stockholders’ equity

$        23,529,743

$        20,791,910

$        21,345,260

(1)

Derived from audited financial statements

(2)

Common shares issued and outstanding were 1,251,278 as of June 28, 2026, 1,250,539 as of March 29, 2026, and 1,268,740 as of June 29, 2025

 

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

Three Months Ended

Twelve Months Ended

June 28,
2026

March 29,
2026

June 29,
2025

June 28,
2026

June 29,
2025

(unaudited)

(unaudited)

(unaudited)

(unaudited)

(1)

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income

$     2,277,282

$     1,825,460

$     1,720,088

$     7,265,396

$     5,358,217

Adjustments to reconcile net income to net cash provided by
operating activities:

Depreciation and amortization

119,642

116,322

98,439

441,533

386,277

Deferred income taxes

(175,752)

(19,478)

(151,679)

(289,062)

(363,247)

Equity-based compensation expense

103,985

96,616

94,286

386,381

343,371

Other, net

(8,006)

(2,855)

14,240

(32,712)

6,845

Changes in operating assets and liabilities

(859,923)

(874,645)

778,814

(1,913,879)

441,801

Net cash provided by operating activities

1,457,228

1,141,420

2,554,188

5,857,657

6,173,264

CASH FLOWS FROM INVESTING ACTIVITIES:

Capital expenditures and intangible assets

(188,801)

(331,604)

(172,191)

(966,405)

(759,186)

Other, net

45,060

(2,976)

42,940

44,253

51,094

Net cash used for investing activities

(143,741)

(334,580)

(129,251)

(922,152)

(708,092)

CASH FLOWS FROM FINANCING ACTIVITIES:

Principal payments on debt, including finance lease
obligations and payments for debt issuance costs

(1,355)

(751,194)

(1,485)

(755,428)

(507,488)

Treasury stock purchases, including excise tax payments

(246,560)

(1,162,837)

(1,292,277)

(3,851,343)

(3,422,321)

Dividends paid

(325,318)

(325,829)

(295,207)

(1,270,635)

(1,149,542)

Reissuance of treasury stock related to employee stock
purchase plan

88,780

79,556

155,965

140,113

Proceeds from issuance of common stock

4,426

9,167

696

17,447

2,452

Other, net

(282)

55

(820)

(13,793)

143

Net cash used for financing activities

(480,309)

(2,230,638)

(1,509,537)

(5,717,787)

(4,936,643)

Effect of exchange rate changes on cash, cash equivalents,
and restricted cash

(2,056)

(4,979)

29,284

(27,431)

28,324

Net change in cash, cash equivalents, and restricted cash

831,122

(1,428,777)

944,684

(809,713)

556,853

Cash, cash equivalents, and restricted cash at beginning of
period (2)

4,766,821

6,195,598

5,462,972

6,407,656

5,850,803

Cash, cash equivalents, and restricted cash at end of period
(2)

$     5,597,943

$     4,766,821

$     6,407,656

$     5,597,943

$     6,407,656

(1)

Derived from audited financial statements

(2)

Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets

 

Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)

Three Months Ended

June 28,
2026

March 29,
2026

Revenue

$     6,722,238

$     5,841,488

Gross margin

$     3,497,336

$     2,913,123

Gross margin as percent of revenue

52.0 %

49.9 %

Operating expenses

$        916,420

$        866,166

Operating income

$     2,580,916

$     2,046,957

Operating margin

38.4 %

35.0 %

Net income

$     2,279,968

$     1,851,442

Net income per diluted share

$              1.82

$              1.47

Shares used in per share calculation – diluted

1,256,032

1,257,325

 

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 

Three Months Ended

June 28,
2026

March 29,
2026

U.S. GAAP net income

$       2,277,282

$       1,825,460

Pre-tax non-GAAP items:

Amortization related to intangible assets acquired through certain business combinations – cost of goods sold

2,668

2,668

Elective deferred compensation (“EDC”) related liability valuation increase (decrease) – cost of goods sold

15,379

(6,476)

Workforce optimization charges – cost of goods sold

549

6,404

EDC related liability valuation increase (decrease) – research and development

27,682

(11,656)

Workforce optimization charges – research and development

960

9,437

Amortization related to intangible assets acquired through certain business combinations – selling, general and
administrative

348

348

EDC related liability valuation increase (decrease) – selling, general and administrative

18,454

(7,771)

Workforce optimization charges –  selling, general and administrative

1,388

6,987

Amortization of note discounts – other income (expense), net

504

674

(Gain) loss on EDC related asset – other income (expense), net

(61,325)

27,265

Net income tax benefit on non-GAAP items

(3,921)

(1,898)

Non-GAAP net income

$       2,279,968

$       1,851,442

Non-GAAP net income per diluted share

$                1.82

$                1.47

U.S. GAAP net income per diluted share

$                1.81

$                1.45

U.S. GAAP and non-GAAP  number of shares used for per diluted share calculation

1,256,032

1,257,325

 

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses, Operating Income and Operating Margin to Non-GAAP
Gross Margin, Operating Expenses, Operating Income and Operating Margin
(in thousands, except percentages)
(unaudited) 

Three Months Ended

June 28,
2026

March 29,
2026

U.S. GAAP gross margin

$     3,478,740

$     2,910,527

Pre-tax non-GAAP items:

Amortization related to intangible assets acquired through certain business combinations

2,668

2,668

EDC related liability valuation increase (decrease)

15,379

(6,476)

Workforce optimization charges

549

6,404

Non-GAAP gross margin

$     3,497,336

$     2,913,123

U.S. GAAP gross margin as a percent of revenue

51.7 %

49.8 %

Non-GAAP gross margin as a percent of revenue

52.0 %

49.9 %

U.S. GAAP operating expenses

$        965,252

$        863,511

Pre-tax non-GAAP items:

Amortization related to intangible assets acquired through certain business combinations

(348)

(348)

EDC related liability valuation (increase) decrease

(46,136)

19,427

Workforce optimization charges

(2,348)

(16,424)

Non-GAAP operating expenses

$        916,420

$        866,166

U.S. GAAP operating income

$     2,513,488

$     2,047,016

Non-GAAP operating income

$     2,580,916

$     2,046,957

U.S. GAAP operating margin

37.4 %

35.0 %

Non-GAAP operating margin

38.4 %

35.0 %

 

Lam Research Corporation Contact:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lam-research-corporation-reports-financial-results-for-the-quarter-ended-june-28-2026-302838154.html

SOURCE Lam Research Corporation

Continue Reading

Trending